Objective:
The coronary calcium score (CCS) predicts cardiovascular disease risk in individuals with diabetes mellitus, and rate of progression of CCS is an additional and incremental marker of risk.
18
F-sodium fluoride positron emission tomography (
18
F-NaF PET) detects early and active calcifications within the vasculature. We aimed to ascertain the relationship between
18
F-NaF PET activity and CCS progression in patients with diabetes mellitus.
Approach and Results:
We identified individuals between 50 and 80 years with diabetes mellitus and no history of clinical coronary artery disease. Those with a CCS ≥10 were invited to undergo
18
F-NaF PET scanning and then repeat CCS >2 years later.
18
F-NaF PET and CCS analysis were performed on a per-coronary and a per-patient level. We compared the proportion of CCS progressors in
18
F-NaF PET–positive versus
18
F-NaF PET–negative coronary arteries. Forty-one participants with 163 coronary arteries underwent follow-up CCS 2.8±0.5 years later.
18
F-NaF PET–positive coronary arteries (n=52) were more likely to be CCS progressors, compared with negative coronary arteries (n=111; 86.5% versus 52.3%,
P
<0.001). Adjusting for baseline CCS,
18
F-NaF PET–positive disease was an independent predictor of subsequent CCS progression (odds ratio, 2.92 [95% CI, 1.32–6.45],
P
=0.008). All subjects (100%, 15/15) with ≥2
18
F-NaF–positive coronary arteries progressed in CCS.
Conclusions:
In subjects with diabetes mellitus,
18
F-NaF PET positivity at baseline, independently predicted the progression of calcifications within the coronary arteries 2.8 years later. These findings suggest
18
F-NaF PET may be a promising technique for earlier identification of patients at higher risk of cardiovascular events.
Molecular Calcium Score from 18F-Sodium Fluoride Positron Emission Tomography to Improve Risk Stratification in Patients with Acute Coronary Syndrome
